Fatigue: Comprehensive Differential Diagnosis and Clinical Approach

1. Introduction to Fatigue: Prevalence, Definition, and Clinical Distinctions

Definition and prevalence: Fatigue is typically defined as a subjective sense of exhaustion, lack of energy, or reduced capacity for physical or mental work disproportionate to recent exertion. It is often described as "tiredness" or "weariness." Population studies indicate that 10–20% of adults experience persistent fatigue lasting more than 2 weeks, with higher rates in women, older adults, and those with chronic medical conditions. In primary care, fatigue accounts for 1–3% of all office visits, and in psychiatry, it is cited as a primary symptom in up to 90% of depressed patients and significant proportions of anxiety patients.

The diagnostic challenge: Fatigue's near-universal symptom profile makes differential diagnosis particularly difficult. It appears in hematologic disease (anemia), endocrine conditions (hypothyroidism, diabetes), cardiac disorders (heart failure), pulmonary disease (COPD), renal failure, hepatic disease, infections (viral, bacterial, parasitic), nutritional deficiencies, neurologic conditions, rheumatologic diseases, malignancy, psychiatric illness (especially depression and anxiety), sleep disorders, and medication side effects. Few symptoms bridge so many physiologic domains. The clinician must balance diagnostic thoroughness with clinical efficiency, avoiding both expensive, unnecessary testing and dangerous oversights.

Physical fatigue vs. mental fatigue vs. sleepiness—crucial distinctions: While these three experiences frequently coexist, distinguishing them yields diagnostic clues:

• Physical fatigue: A sensation of muscular weakness, reduced endurance, or physical exhaustion. Patients report inability to perform usual physical tasks (climbing stairs, exercising) despite adequate sleep. Suggests cardiovascular, hematologic, metabolic, or neuromuscular pathology.
• Mental fatigue (cognitive fatigue): Difficulty concentrating, mental sluggishness, reduced motivation, or executive dysfunction. Patients describe inability to think clearly, organize thoughts, or maintain attention. Highly prevalent in depression, anxiety, and cognitive disorders; also seen in sleep disorders and neurologic conditions.
• Sleepiness (somnolence): Propensity to fall asleep, difficulty maintaining wakefulness, or irresistible urge to sleep. Distinct from fatigue; a person can feel fatigued yet remain alert, or conversely, be sleepy without feeling fatigued. Specific to sleep disorders (obstructive sleep apnea, narcolepsy, insufficient sleep), but also occurs with medications and neurologic conditions.

Careful history-taking to distinguish these three dimensions substantially narrows the differential diagnosis and directs testing appropriately.

2. The Broad Differential Diagnosis: Organized by Organ System

3. How to Approach the Complaint of Fatigue: Structured Clinical Interview

A systematic, efficient history is essential for narrowing the differential:

Onset and duration: Acute fatigue (days to weeks) suggests infection, metabolic derangement, depression onset, or medication reaction. Subacute fatigue (weeks to months) may represent thyroid disease, anemia, malignancy, or developing psychiatric illness. Chronic fatigue (months to years) raises fibromyalgia, chronic fatigue syndrome/ME-CFS, chronic psychiatric conditions, or longstanding medical disease. Fluctuating fatigue suggests mood disorder, sleep variability, or medication effect.

Course and pattern: Does fatigue improve with rest? If yes, suggests physical deconditioning or depression (rest may worsen mood). If no, suggests systemic illness, sleep disorder, or neurologic condition. Morning vs. afternoon vs. evening predominance offers clues: morning fatigue may indicate poor sleep quality, depression, sleep apnea, or adrenal insufficiency; afternoon fatigue may reflect post-lunch glucose dip (diabetes) or circadian nadir; evening fatigue is more typical of normal physiology but may be exaggerated in anemia or cardiac disease.

Associated symptoms—sleep quality: Is sleep adequate in duration (≥7 hours) but unrefreshed? Suggests sleep disorder (OSA, periodic leg movements, insomnia with arousals). Is the patient sleeping excessively (>10 hours) yet still fatigued? May indicate depression, hypothyroidism, sleep apnea, or narcolepsy. Does the patient report insomnia, frequent awakenings, or early morning awakening? Strongly suggestive of depression or primary insomnia. Snoring, witnessed apneas, or gasping at night points to obstructive sleep apnea.

Mood and psychiatric history: Screen carefully for depression (anhedonia, guilt, worthlessness, suicidal ideation), anxiety (worry, panic, hypervigilance), and prior psychiatric episodes. A temporal relationship between fatigue onset and depressive symptoms is highly suggestive. Inquire about stress, loss, trauma, or life changes.

Medication and substance review: Many medications cause fatigue: SSRIs, beta-blockers, antihistamines, benzodiazepines, antipsychotics, anticholinergics, statins, antihypertensives. Alcohol and cannabis are common culprits. Opioid overuse causes sedation and fatigue. Always check if fatigue began shortly after starting a medication.

Constitutional symptoms—red flags: Weight loss (unintentional, especially >10% in 6 months) raises malignancy, hyperthyroidism, diabetes, or chronic infection. Night sweats (drenching, waking the patient) suggest lymphoma, tuberculosis, endocarditis, or other infections. Fever indicates infection or malignancy. Lymphadenopathy, hepatosplenomegaly, or skin rashes warrant imaging and laboratory evaluation.

Systemic review by organ system: Dyspnea on exertion or orthopnea suggests cardiac or pulmonary disease, or anemia. Edema indicates heart failure or renal disease. Chest pain, palpitations, or syncope are cardiac red flags. Abdominal pain, jaundice, or pale stools suggest hepatic or gastrointestinal pathology. Joint pain or swelling raises rheumatologic disease. Cognitive complaints or neurologic symptoms suggest neurologic or psychiatric pathology. Changes in bowel habits, urinary symptoms, or menstrual irregularities offer additional clues.

Exercise tolerance and physical capability: Ask specifically: "How far can you walk before feeling fatigued? Can you climb stairs? Do household chores?" Inability to perform baseline activities suggests medical pathology (cardiac, pulmonary, hematologic) or severe depression. In contrast, "I'm too tired to try" without objective limitation suggests depression.

4. First-Line Testing: Complete Blood Count, Metabolic Panel, TSH, Urinalysis, and Inflammatory Markers

Most clinicians reasonably begin with a "screening panel" that captures the most common and medically significant causes:

Complete blood count (CBC) with differential: Detects anemia (most common hematologic cause), leukopenia (infection, malignancy, medications), thrombocytopenia (bone marrow disorders, medications, autoimmune), and relative lymphocytosis (viral infection) or left shift (bacterial infection). An elevated WBC count with left shift suggests acute infection. Macrocytic anemia (MCV >100) points to B12/folate deficiency or alcohol abuse. Microcytic anemia (MCV <80) suggests iron deficiency or chronic disease. Anemia severity correlates with fatigue; even mild anemia (hemoglobin 10–12 g/dL) causes noticeable fatigue in many patients.

Comprehensive metabolic panel (CMP): Includes electrolytes, glucose, renal function, and liver function. Hyperglycemia or HbA1c elevation (if diabetes screening is added) suggests diabetes or prediabetes. Elevated creatinine or low eGFR indicates chronic kidney disease, a major cause of fatigue. Hyponatremia or hypokalemia causes weakness and fatigue. Elevated AST/ALT suggests hepatitis or liver disease. Hypercalcemia (from hyperparathyroidism or malignancy) causes fatigue. Low albumin suggests malnutrition or chronic liver disease.

Thyroid-stimulating hormone (TSH): Essential; hypothyroidism is among the most common medical causes of fatigue and is easily missed if not screened. TSH elevation (typically >4.0 mIU/L, though normal range varies by lab) indicates primary hypothyroidism and warrants levothyroxine. TSH suppression (<0.1) suggests hyperthyroidism (less commonly a cause of pure fatigue, but important to exclude). If TSH is abnormal, check free T4 and anti-TPO antibodies for confirmation.

Urinalysis: Screens for urinary tract infection (pyuria, bacteriuria, leukocyte esterase), glycosuria (undiagnosed diabetes), proteinuria (kidney disease, lupus), and hematuria (malignancy, kidney stone, glomerulonephritis). Infection may present with fatigue as the primary complaint, especially in older adults.

Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP): These nonspecific inflammatory markers are elevated in rheumatologic disease, chronic infection, malignancy, and inflammatory bowel disease. An elevated ESR/CRP without other obvious findings warrants further investigation (ANA, rheumatoid factor, chest X-ray, infectious workup).

5. Second-Line Testing: When History and Initial Labs Suggest Specific Etiologies

If first-line testing is unrevealing but clinical suspicion remains, targeted second-line testing is warranted:

Iron studies (serum ferritin, total iron-binding capacity [TIBC], serum iron, transferrin saturation): If CBC shows microcytic or normocytic anemia, or if history suggests iron loss (heavy menses, GI bleeding), obtain iron studies. Low ferritin (<30 ng/mL) indicates iron deficiency; however, ferritin is an acute-phase reactant and may be falsely elevated in inflammation. TIBC and transferrin saturation help clarify. Iron deficiency without anemia (normal hemoglobin but low ferritin) causes fatigue in some patients and may warrant supplementation.

Vitamin B12 and folate levels: Indicated if macrocytic anemia is present, if patient has risk factors (veganism, pernicious anemia, malabsorption, chronic metformin use, prior gastrointestinal surgery), or if neurologic symptoms (paresthesias, ataxia) are present. B12 deficiency can cause fatigue without anemia (subclinical deficiency). If B12 is borderline (200–400 pg/mL), check methylmalonic acid (MMA) and homocysteine; elevation suggests true B12 deficiency despite "normal-range" B12 level.

Hemoglobin A1c or fasting glucose: Screen all patients with fatigue, particularly those with weight gain, thirst, or polyuria. Prediabetes (HbA1c 5.7–6.4%) and diabetes (HbA1c ≥6.5%) are common causes of fatigue.

Vitamin D (25-hydroxyvitamin D): Deficiency (<20 ng/mL) is extremely common, particularly in northern climates and dark-skinned populations. Vitamin D deficiency causes bone pain, muscle weakness, and fatigue. Repletion often improves symptoms. Level >20 ng/mL is generally adequate; >30 ng/mL is optimal for bone health and immune function.

Hepatitis panel (anti-HCV, anti-HBc, HBsAg, AST/ALT): If risk factors for hepatitis are present (IV drug use, transfusion, sexual exposure, liver disease history) or if LFTs are abnormal. Chronic hepatitis C is a common cause of fatigue and is highly treatable.

HIV antibody/antigen test: If risk factors or if first-line testing is unrevealing with constitutional symptoms. AIDS-related fatigue can be severe.

6. Third-Line Testing: Advanced Evaluation for Diagnostic Uncertainty

If history, examination, and first- and second-line testing remain inconclusive, third-line testing is warranted:

Antinuclear antibody (ANA) and other rheumatologic markers: If fatigue is accompanied by joint pain, rash, Raynaud's phenomenon, dry eyes/mouth, or elevated inflammatory markers. ANA screening is sensitive for systemic lupus erythematosus, Sjögren's syndrome, and other connective tissue diseases.

Morning cortisol (8–9 AM) and ACTH: If clinical suspicion for adrenal insufficiency exists (hypotension, hypoglycemia, GI symptoms, hyperpigmentation). A morning cortisol <5 mcg/dL is abnormally low; >15 mcg/dL makes adrenal insufficiency unlikely. If borderline (5–15 mcg/dL), proceed to ACTH stimulation test (cosyntropin challenge).

Testosterone (total and free) and luteinizing hormone (LH): In men with fatigue, low libido, or erectile dysfunction. Hypogonadism (testosterone <300 ng/dL) causes significant fatigue and may respond to replacement therapy. Check LH to distinguish primary (elevated LH) from secondary (low LH) hypogonadism.

Sleep study referral (polysomnography or home sleep apnea testing): If clinical suspicion for obstructive sleep apnea (snoring, witnessed apneas, daytime sleepiness, obesity) or if fatigue is accompanied by unrefreshed sleep despite adequate duration. Polysomnography is the gold standard; home sleep testing is convenient and acceptable for moderate-to-high pretest probability of OSA.

Chest X-ray: If dyspnea, cough, or respiratory symptoms accompany fatigue, or if OSA is suspected (to rule out cor pulmonale). Also consider if constitutional symptoms (fever, weight loss) without clear etiology.

Echocardiogram: If cardiac symptoms, murmur on exam, or dyspnea on exertion. Assesses ejection fraction, wall motion abnormalities, and valvular disease.

Specialty referrals: Cardiology for suspected heart failure, pulmonology for COPD/ILD, gastroenterology for suspected IBD or malabsorption, neurology for progressive neurologic symptoms, sleep medicine for refractory insomnia or suspected narcolepsy.

7. Obstructive Sleep Apnea and Other Sleep Disorders: Recognition and Management

Sleep disorders are extraordinarily common causes of fatigue and are frequently missed if not specifically screened:

Obstructive sleep apnea (OSA) prevalence and screening: OSA affects 2–7% of adults (up to 25–50% in obese populations). Patients experience repeated airway collapse during sleep, resulting in apneas (complete cessation of airflow ≥10 seconds) or hypopneas (significant reduction in airflow). Each event triggers microarousals and oxygen desaturation. Patients wake feeling unrefreshed, experience significant daytime sleepiness, and often complain of fatigue. The STOP-BANG screening questionnaire identifies high-risk patients: Snoring, Tiredness during daytime, Observed apneas, high blood Pressure, BMI >35, Age >50, Neck circumference >40 cm, male Gender. Presence of three or more criteria warrants sleep study referral.

Sleep study modalities: Gold-standard polysomnography (in-lab, attended) provides comprehensive assessment (EEG, EMG, EOG, heart rate, oxygen saturation, airflow, respiratory effort). Home sleep apnea testing (HSAT) is more convenient and cost-effective for moderate-to-high pretest probability OSA; it measures oxygen saturation, heart rate, airflow, and respiratory effort but not sleep staging. Both modalities quantify apnea-hypopnea index (AHI, events/hour); AHI ≥5 indicates OSA (mild: 5–15, moderate: 15–30, severe: >30).

Treatment: Continuous positive airway pressure (CPAP) is first-line. A heated, humidified mask delivers pressurized air to splint the airway patent. CPAP dramatically improves sleep quality, daytime alertness, and fatigue in many patients, though adherence is a challenge (patients often abandon treatment due to mask discomfort or claustrophobia). Alternative devices include bilevel positive airway pressure (BiPAP), which allows lower pressure during exhalation, and newer oral appliances for mild-to-moderate OSA.

Restless legs syndrome (RLS): Characterized by an irresistible urge to move legs (often accompanied by uncomfortable sensations: tingling, aching, crawling) in the evening and at night, especially when sitting or lying. Movement brings relief. RLS disrupts sleep quality, causing unrefreshed sleep and daytime fatigue. Diagnosis is clinical; periodic limb movement polysomnography shows repetitive leg jerks. Associated with iron deficiency (check ferritin), kidney disease, pregnancy, and idiopathic causes. Treatment: iron supplementation if deficient, dopamine agonists (pramipexole, ropinirole), gabapentin, or opioids for refractory cases.

Periodic limb movement disorder (PLMD): Similar to RLS but occurs during sleep without daytime symptoms. Polysomnography shows periodic leg jerks (myoclonus). Causes frequent arousals and unrefreshed sleep. Treatment similar to RLS.

Narcolepsy: Rare but important. Characterized by excessive daytime sleepiness (irresistible urges to nap during day), cataplexy (sudden loss of muscle tone triggered by emotion—laughter, surprise, anger), sleep paralysis (inability to move upon waking), and hypnagogic/hypnopompic hallucinations. Caused by deficiency of hypocretin (orexin) neurotransmitter. Diagnosed via multiple sleep latency test (MSLT) and polysomnography. Treatment: stimulants (modafinil, amphetamines), sodium oxybate, or recent agents targeting orexin receptors. Often misdiagnosed as depression or ADHD.

Circadian rhythm sleep disorders: Delayed sleep phase syndrome (patient falls asleep and wakes too late), advanced sleep phase syndrome (patient falls asleep and wakes too early), or irregular sleep-wake rhythm. Circadian misalignment causes poor sleep quality and daytime fatigue. Treatment: light therapy, melatonin, behavioral sleep scheduling.

8. When Fatigue Remains Unexplained: Chronic Fatigue Syndrome and ME-CFS

After thorough history, physical examination, and appropriate first-, second-, and third-line testing, some patients have persistent fatigue without identifiable organic cause. In these cases, consider chronic fatigue syndrome (CFS), also termed myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) by international consensus.

Diagnostic criteria for ME/CFS: The 2015 Institute of Medicine (now National Academies) criteria require (1) substantial impairment in occupational, educational, social, or personal functioning; (2) new-onset fatigue (not lifelong) of at least 6 months duration; and (3) postexertional malaise—symptom worsening after exertion (physical or cognitive) that is disproportionate to the exertion and requires prolonged recovery (often 24+ hours). Additionally, unrefreshing sleep is required, and at least one of two cognitive symptoms (impaired memory or concentration) or orthostatic intolerance (lightheadedness upon standing) must be present.

Important diagnostic exclusions: ME/CFS is a diagnosis of exclusion. Patients with untreated major depression, bipolar disorder, schizophrenia, substance use disorders, or severe obesity are excluded. Active malignancy, untreated hypothyroidism, untreated sleep apnea, and other identifiable medical/psychiatric conditions must be ruled out before diagnosing ME/CFS.

Epidemiology and pathophysiology: ME/CFS affects approximately 0.4% of the general population (up to 2.6 million Americans). It typically begins after a viral illness (EBV, COVID-19), physical trauma, or extreme stress. Proposed mechanisms include persistent viral reactivation, immune dysregulation, mitochondrial dysfunction, and autonomic dysfunction. No specific diagnostic test exists; diagnosis is clinical.

Management approach: There is no proven cure. Management is supportive and individualized: (1) Pacing strategies—gradually increase activity while monitoring for postexertional malaise; avoid "boom-bust" cycles where patients overexert then crash; (2) Sleep optimization—address poor sleep hygiene, consider low-dose sleep aids if appropriate; (3) Symptom management—pain control with acetaminophen or NSAIDs, antihistamines for allergic symptoms; (4) Psychological support—cognitive-behavioral therapy (CBT) and graded exercise therapy (GET) have modest supportive evidence, though patients often report GET worsens symptoms; (5) Exclude and manage comorbid conditions—depression, anxiety, orthostatic intolerance, which are common in ME/CFS and may respond to targeted treatment. Some patients benefit from cardiology evaluation for autonomic dysfunction (prolonged Tilt test may reveal dysautonomia).

Prognosis: Variable; some patients improve over time, others remain severely impaired. No reliable predictors of outcome. Support groups and patient advocacy organizations (e.g., ME/CFS Alliance) provide valuable resources.

9. Clinical Summary: A Rational Approach to Fatigue Evaluation

Evaluating fatigue efficiently and accurately requires three complementary steps:

Red flags requiring urgent evaluation and possible hospitalization: Acute dyspnea, chest pain, syncope, significant orthostatic hypotension, acute severe anemia, or altered mental status warrant immediate evaluation. Weight loss >10% in 6 months, night sweats, or lymphadenopathy require imaging (CT, chest X-ray) and oncology consultation if malignancy is suspected.

When to involve subspecialties: Cardiology for suspected heart failure or arrhythmia; pulmonology for COPD or restrictive lung disease; endocrinology for diabetes, thyroid disease, or adrenal insufficiency; hematology-oncology if anemia is severe or malignancy suspected; rheumatology if autoimmune disease (ANA-positive, elevated inflammatory markers); sleep medicine for suspected sleep disorders; neurology for progressive neurologic symptoms; and psychiatry for major depression or anxiety disorders.